J&J Opens Device R&D Center In China For Growing Rural Market
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Johnson & Johnson and its device company in China Johnson & Johnson Medical (Suzhou) Ltd. will open a new innovation center in Suzhou to develop medical devices and diagnostic products for emerging markets in Asia
You may also be interested in...
Emerging Markets Earnings Roundup: J&J, Abbott And Roche (Part 1)
Abbott moved to recover from recall and pricing issues for infant formula in China while Johnson & Johnson updated its device business and Roche reported strong growth in emerging markets.
Emerging Markets Earnings Roundup: J&J, Abbott And Roche (Part 1)
Abbott moved to recover from recall and pricing issues for infant formula in China while Johnson & Johnson updated its device business and Roche reported strong growth in emerging markets.
Janssen Closer To End-To-End R&D Model With New Research Center In Shanghai
Janssen has placed a further bet on China R&D by establishing a pharmaceutical discovery laboratory in Shanghai’s Fenglin Life Science Park.